(Q48716821)

14 February 2018

title

Effect of topical nasal azelastine on the symptoms of rhinitis, sleep, and daytime somnolence in perennial allergic rhinitis. (English)

1 reference

14 February 2018

1 reference

Golden S

1

1 reference

14 February 2018

Teets SJ

2

1 reference

14 February 2018

Lehman EB

3

1 reference

14 February 2018

Mauger EA

4

1 reference

14 February 2018

Chinchilli V

5

1 reference

14 February 2018

Berlin JM

6

1 reference

14 February 2018

Kakumanu S

7

1 reference

14 February 2018

Lucus T

8

1 reference

14 February 2018

Craig TJ

9

1 reference

14 February 2018

publication date

1 July 2000

1 reference

14 February 2018

Annals of Allergy, Asthma & Immunology

published in

1 reference

14 February 2018

volume

85

1 reference

14 February 2018

issue

1

1 reference

14 February 2018

page(s)

53-57

1 reference

14 February 2018

Nasal congestion secondary to allergic rhinitis as a cause of sleep disturbance and daytime fatigue and the response to topical nasal corticosteroids

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962434-9

7 January 2021

A double-blind, controlled trial to assess the safety and efficacy of azelastine nasal spray in seasonal allergic rhinitis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962434-9

7 January 2021

Antagonism of histamine and leukotrienes by azelastine in isolated guinea pig ileum

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962434-9

7 January 2021

Inhibition of cytokine production from human peripheral blood leukocytes by anti-allergic agents in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962434-9

7 January 2021

Inhibitory effect of azelastine, a potent antiallergic agent, on release of tumor necrosis factor-alpha from activated human peripheral blood mononuclear cells and U937 cells

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962434-9

7 January 2021

Inhibitory effects of azelastine hydrochloride on Ca2+ influx, actin polymerization and release of eosinophil cationic protein of an eosinophilic leukaemia cell line EoL-1.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962434-9

7 January 2021

Inhibition of leukotriene synthesis by azelastine

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962434-9

7 January 2021

Effect of azelastine on leukotriene synthesis in murine peritoneal cells and on thromboxane synthesis in human platelets

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962434-9

7 January 2021

Safety and efficacy of azelastine nasal spray (Astelin NS) for seasonal allergic rhinitis: a 4-week comparative multicenter trial

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962434-9

7 January 2021

A New Method for Measuring Daytime Sleepiness: The Epworth Sleepiness Scale

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962434-9

7 January 2021

Nasal obstruction as a risk factor for sleep-disordered breathing. The University of Wisconsin Sleep and Respiratory Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962434-9

7 January 2021

A dose-ranging study of the efficacy and safety of azelastine nasal spray in the treatment of seasonal allergic rhinitis with an acute model

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962434-9

7 January 2021

Sedation in allergic rhinitis is caused by the condition and not by antihistamine treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962434-9

7 January 2021

Beneficial effects of propylene and polyethylene glycol and saline in the treatment of perennial rhinitis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962434-9

7 January 2021

10.1016/S1081-1206(10)62434-9

Identifiers

DOI

1 reference

14 February 2018

PubMed ID

10923605

1 reference

14 February 2018